Continuous Glucose Monitors and Health Support for Type 1 Diabetes in New Zealand
Continuous Glucose Monitors Funded in New Zealand
Continuous glucose monitors (CGMs) for managing type 1 diabetes have recently received funding in New Zealand, a major milestone in diabetes care. These devices enhance the ability to monitor blood glucose levels and improve health outcomes for those reliant on insulin therapy.
Workforce Challenges Affecting Diabetes Care
Despite this funding, New Zealand faces a significant challenge: a chronic workforce shortage in the healthcare sector. To fully leverage the benefits of newly funded health technology like CGMs and insulin pumps, the country must urgently double its healthcare workforce supporting diabetes care.
- Pharmac has taken a crucial step in enabling access to advanced medical technologies.
- Te Whatu Ora is pivotal in implementing the necessary changes for effective resource distribution.
- The funding could lead to better management of health conditions in the long run.
Conclusion
For New Zealand to fulfill international diabetes care guidelines, there is a pressing need to address workforce shortages. The new funding for continuous glucose monitors is a positive development, provided that adequate support systems are in place.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.